The QuartzBioSM advantage
- Unrivaled speed and assimilation of all biomarker data from high-content to high-throughput
- Transparent, immediate insight into all layers of the harmonized biomarker data
- Visibility into the hierarchical nature of biological data (eg, access to raw images, gating schema for flow cytometry data, and more)
- Access to the depth of biomarker data and contextual information
- Exploration at an unprecedented rate, enabling you to assess PD effects, guide dose selection, and stratify patients more efficiently
Access all of your biomarker and key clinical data at the click of a mouse—in a single, secure cloud-based solution that is 21 CFR Part 11 compliant
QuartzBio technology platform for translational research
Technology rapidly surfaces the utility of complex data
The QuartzBio platform manages complex biomarker data and delivers it in a format you can use to advance your research. The platform rapidly assimilates data, then offers advanced visualization, analysis, secure access, and on-demand reporting—all in compliance with 21 CFR Part 11 standards.
A single phase 1 study may encompass more than 10 million data points—that’s why we created QuartzBio. This unprecedented platform can address an array of biomarker assay technologies simultaneously, no matter how high-content or high-throughput the data may be. Complex flow cytometry. Immunosequencing. Next generation sequencing. QuartzBio can handle them all—and more.